GlassScriptPhysician profile
Kevin J Connor
NPI 1821018953
$14,897.75
in general payments reported to CMS, 2019-2025
52 companies · $2,871 in 2025
The $2,871 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,242 · 2020: $1,120 · 2021: $2,042 · 2022: $2,099 · 2023: $2,708 · 2024: $2,816 · 2025: $2,871.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,395.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,089.43 | 2019-2025 | Vraylar, Ubrelvy, Qulipta |
| Novo Nordisk INC | $1,808.64 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,473.31 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $1,289.64 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Pfizer INC. | $937.94 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $802.71 | 2019-2025 | Jardiance |
| Glaxosmithkline, LLC. | $801.04 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novartis Pharmaceuticals Corporation | $581.10 | 2021-2025 | |
| Astellas Pharma US INC | $569.74 | 2019-2025 | Veozah, Myrbetriq |
| Biohaven Pharmaceuticals, INC. | $496.65 | 2021 | |
| Amarin Pharma, INC. | $415.85 | 2019-2023 | |
| Teva Pharmaceuticals USA, INC. | $302.74 | 2021-2024 | Austedo Xr, Ajovy, Austedo |
| Biohaven Pharmaceutical Holding Company LTD. | $268.90 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $266.74 | 2019-2025 | Xifaxan |
| Merck Sharp & Dohme LLC | $253.18 | 2019-2025 | Capvaxive, Belsomra |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $234.07 | 2023-2025 | |
| Amgen INC. | $232.09 | 2019-2025 | Otezla, Repatha, Otezla |
| Kowa Pharmaceuticals America, INC. | $172.89 | 2019-2025 | Zoryve, Livalo, Seglentis |
| Janssen Pharmaceuticals, INC | $141.46 | 2019-2024 | Xarelto |
| Abbott Laboratories | $135.61 | 2023-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Sanofi-Aventis U.S. LLC | $131.56 | 2019-2025 | |
| Allergan, INC. | $121.04 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $110.65 | 2024-2025 | Rexulti |
| Eisai INC. | $108.47 | 2021-2024 | |
| Phathom Pharmaceuticals, INC. | $100.48 | 2023-2025 | Voquezna |
| E.R. Squibb & Sons, L.L.C. | $98.73 | 2020-2025 | Camzyos, Eliquis |
| Idorsia Pharmaceuticals US INC | $88.11 | 2023-2024 | Quviviq |
| Takeda Pharmaceuticals U.S.A., INC. | $78.52 | 2022-2023 | Gattex |
| Dexcom, INC. | $75.87 | 2025 | Dexcom G6 Transmitter |
| Optinose US, INC. | $71.97 | 2022-2025 | |
| Exact Sciences Corporation | $63.40 | 2025 | Cologuard Collection Kit |
| Sanofi Pasteur INC. | $61.25 | 2019-2024 | |
| Corcept Therapeutics | $53.18 | 2025 | Korlym |
| Genentech USA, INC. | $48.31 | 2019-2022 | |
| Ucb, INC. | $47.59 | 2023 | Briviact |
| Amneal Pharmaceuticals LLC | $44.69 | 2021-2022 | |
| Almatica Pharma LLC | $35.94 | 2025 | Loreev Xr |
| Esperion Therapeutics, INC. | $28.73 | 2024 | Nexletol |
| Lundbeck LLC | $24.77 | 2025 | Rexulti |
| Inspire Medical Systems, INC. | $23.78 | 2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $22.43 | 2019 | |
| Alexion Pharmaceuticals, INC. | $20.74 | 2022 | |
| Shire North American Group INC | $20.59 | 2019 | |
| Scilex Pharmaceuticals INC. | $19.38 | 2023 | Ztlido |
| Phadia US INC. | $18.53 | 2023 | Immunocap |
| Currax Pharmaceuticals LLC | $17.41 | 2025 | Contrave |
| Biogen, INC. | $17.16 | 2024 | Leqembi |
| Seqirus USA INC | $15.48 | 2019 | |
| Xeris Pharmaceuticals, INC. | $14.64 | 2024 | Gvoke Hypopen |
| Bausch Health US, LLC | $14.50 | 2020 | |
| Shield Therapeutics INC | $13.72 | 2025 | |
| Hikma Pharmaceuticals USA | $12.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Connor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.